AETHLON MEDICAL INC (Nasdaq:AEMD)
Health Care/Life Sciences • Medical Equipment/Supplies
CIK 882291
Company
Aethlon Medical, Inc. is a medical technology company which focuses on developing products to diagnose and treat life and organ threatening diseases. It develops Aethlon Hemopurifier, which is a clinical-stage immunotherapeutic device designed to combat cancer and life-threatening viral infections. The firm operates through the following segments: Aethlon and ESI. The Aethlon segment is involved in therapeutic business activities. The ESI segment consists of diagnostic business activities. The company was founded by James A. Joyce in 1991 and is headquartered in San Diego, CA.
Address
11555 Sorrento Valley Road
Suite 203
San Diego, California 92121
11555 Sorrento Valley Road
Suite 203
San Diego, California 92121
Employees
15
15
Stock Info
Close
$1.7299
$1.7299
Day Range
1.6600 - 1.7300
1.6600 - 1.7300
52 Week Range
1.4000 - 7.2000
1.4000 - 7.2000
Average volume
16.86K
16.86K
Short Interest
6.84K (02/15/24)
6.84K (02/15/24)
% of Float Shorted
0.27%
0.27%
Market Cap
$4.32M
$4.32M
Revenue
$574.25K
$574.25K
Net Income
-$12.03M
-$12.03M
2020 Sales Growth
N/A
N/A
Key Executives
Board Of Directors
|
CEO, Chief Financial Officer, Secretary & Director James B Frakes MBA |
|
Chairman Edward G Broenniman MBA |
|
Independent Director Angela Rossetti MBA |
|
Independent Director Nicolas Gikakis MBA |
|
Independent Director Chetan S Shah MD |
SEC filings
| Date | Form | Event |
|---|---|---|
| 3 Oct, 2024 | 8-K | |
| 2 Oct, 2024 | 8-K | |
| 1 Oct, 2024 | 4 | |
| 1 Oct, 2024 | 4 | |
| 1 Oct, 2024 | 4 | |
| 19 Sep, 2024 | 8-K | |
| 15 Aug, 2024 | DEF 14A | |
| 15 Aug, 2024 | DEFA14A | |
| 15 Aug, 2024 | ARS | |
| 15 Aug, 2024 | 10-K/A | |
| 14 Aug, 2024 | 10-Q | |
| 14 Aug, 2024 | 8-K | |
| 12 Aug, 2024 | 8-K | |
| 3 Jul, 2024 | 8-K | |
| 1 Jul, 2024 | 4 | |
| 1 Jul, 2024 | 4 | |
| 1 Jul, 2024 | 4 | |
| 27 Jun, 2024 | 10-K | |
| 27 Jun, 2024 | 8-K | |
| 24 May, 2024 | 8-K | |
| 17 May, 2024 | 8-K | |
| 16 May, 2024 | EFFECT | |
| 16 May, 2024 | 424B4 | |
| 15 May, 2024 | POS AM | |
| 15 May, 2024 | EFFECT | |
| 13 May, 2024 | S-1/A | |
| 10 May, 2024 | CORRESP | |
| 10 May, 2024 | 8-K | |
| 10 May, 2024 | CORRESP | |
| 25 Apr, 2024 | S-1/A | |
| 25 Apr, 2024 | 8-K | |
| 17 Apr, 2024 | 4 | |
| 17 Apr, 2024 | 4 | |
| 17 Apr, 2024 | 4 | |
| 17 Apr, 2024 | 4 | |
| 5 Apr, 2024 | S-1/A | |
| 1 Apr, 2024 | 4 | |
| 1 Apr, 2024 | 4 | |
| 1 Apr, 2024 | 4 | |
| 28 Mar, 2024 | UPLOAD | |
| 22 Mar, 2024 | S-1 | |
| 14 Feb, 2024 | 8-K | |
| 14 Feb, 2024 | 10-Q | |
| 2 Jan, 2024 | 4 | |
| 2 Jan, 2024 | 4 | |
| 2 Jan, 2024 | 4 | |
| 22 Dec, 2023 | 8-K/A | |
| 27 Nov, 2023 | 8-K | CEO Change |
| 14 Nov, 2023 | 10-Q | |
| 14 Nov, 2023 | 8-K | |
| 13 Nov, 2023 | 8-K | CEO Change |
| 4 Oct, 2023 | 8-K | |
| 29 Sep, 2023 | 4 | |
| 29 Sep, 2023 | 4 | |
| 29 Sep, 2023 | 4 | |
| 18 Sep, 2023 | 8-K | |
| 10 Aug, 2023 | 8-K | |
| 10 Aug, 2023 | 10-Q | |
| 27 Jul, 2023 | DEF 14A | |
| 27 Jul, 2023 | ARS | |
| 17 Jul, 2023 | PRE 14A | |
| 6 Jul, 2023 | 4 | |
| 6 Jul, 2023 | 3 | |
| 6 Jul, 2023 | 8-K | |
| 3 Jul, 2023 | 4 | |
| 3 Jul, 2023 | 4 | |
| 28 Jun, 2023 | 8-K | |
| 28 Jun, 2023 | 10-K | |
| 1 May, 2023 | 4 | |
| 1 May, 2023 | 4 | |
| 1 May, 2023 | 4 | |
| 25 Apr, 2023 | 8-K | |
| 31 Mar, 2023 | 4 | |
| 31 Mar, 2023 | 4 | |
| 13 Feb, 2023 | 8-K | |
| 13 Feb, 2023 | 10-Q | |
| 2 Feb, 2023 | 3 | |
| 2 Feb, 2023 | 4 | |
| 30 Dec, 2022 | 4 | |
| 30 Dec, 2022 | 4 | |
| 14 Nov, 2022 | 10-Q | |
| 14 Nov, 2022 | 8-K | |
| 27 Oct, 2022 | 8-K | |
| 4 Oct, 2022 | 4 | |
| 4 Oct, 2022 | 4 | |
| 29 Sep, 2022 | 424B5 | |
| 29 Sep, 2022 | 8-K | |
| 29 Sep, 2022 | 8-K | |
| 19 Sep, 2022 | S-8 | |
| 19 Sep, 2022 | 8-K | |
| 16 Sep, 2022 | 4 | |
| 16 Sep, 2022 | 4 | |
| 16 Sep, 2022 | 4 | |
| 9 Aug, 2022 | 8-K | |
| 9 Aug, 2022 | 10-Q | |
| 3 Aug, 2022 | 424B5 | |
| 27 Jul, 2022 | DEF 14A | |
| 15 Jul, 2022 | PRE 14A | |
| 28 Jun, 2022 | 8-K | |
| 28 Jun, 2022 | 10-K | |
| 1 Apr, 2022 | 3 | |
| 31 Mar, 2022 | 4 | |
| 31 Mar, 2022 | 4 | |
| 31 Mar, 2022 | 4 | |
| 28 Mar, 2022 | 8-K | |
| 24 Mar, 2022 | 8-K | |
| 24 Mar, 2022 | 424B5 | |
| 14 Feb, 2022 | 10-Q | |
| 14 Feb, 2022 | 8-K | |
| 11 Feb, 2022 | 4 | |
| 11 Feb, 2022 | 4 | |
| 11 Feb, 2022 | 4 | |
| 11 Feb, 2022 | 4 | |
| 13 Jan, 2022 | SC 13G/A | |
| 3 Jan, 2022 | 4 | |
| 3 Jan, 2022 | 4 | |
| 3 Jan, 2022 | 4 | |
| 9 Nov, 2021 | 8-K | |
| 9 Nov, 2021 | 10-Q | |
| 1 Nov, 2021 | 8-K | |
| 21 Oct, 2021 | EFFECT | |
| 1 Oct, 2021 | 4 | |
| 1 Oct, 2021 | 4 | |
| 1 Oct, 2021 | 4 | |
| 30 Sep, 2021 | S-3 | |
| 17 Sep, 2021 | 8-K | |
| 9 Aug, 2021 | 8-K | |
| 9 Aug, 2021 | 10-Q | |
| 28 Jul, 2021 | DEF 14A | |
| 28 Jul, 2021 | DEFA14A | |
| 1 Jul, 2021 | 4 | |
| 1 Jul, 2021 | 4 | |
| 1 Jul, 2021 | 4 | |
| 1 Jul, 2021 | 8-K | |
| 30 Jun, 2021 | 4 | |
| 24 Jun, 2021 | 10-K | |
| 24 Jun, 2021 | 8-K | |
| 15 Jun, 2021 | SC 13G | |
| 11 Jun, 2021 | 8-K | |
| 11 Jun, 2021 | 424B5 | |
| 2 Apr, 2021 | 4 | |
| 2 Apr, 2021 | 4 | |
| 2 Apr, 2021 | 4 | |
| 2 Apr, 2021 | 4 | |
| 2 Apr, 2021 | 4 | |
| 22 Mar, 2021 | 8-K | |
| 22 Mar, 2021 | 424B5 | |
| 22 Feb, 2021 | SC 13G/A | |
| 10 Feb, 2021 | 8-K | |
| 10 Feb, 2021 | 10-Q | |
| 29 Jan, 2021 | SC 13G/A | |
| 13 Jan, 2021 | SC 13G | |
| 11 Jan, 2021 | 8-K | |
| 7 Jan, 2021 | 3 | |
| 7 Jan, 2021 | 4 | |
| 6 Jan, 2021 | 4 | |
| 4 Jan, 2021 | 4 | |
| 4 Jan, 2021 | 4 | |
| 4 Jan, 2021 | 4 | |
| 4 Jan, 2021 | 4 | |
| 4 Jan, 2021 | 4 |
Last update:2024-03-06 12:11:11.231338
Sign Up to Subscribe
Interested in special situations?
Join Tickerverse
- customize event filters
- create watchlists, bookmarks
- get email notifications for the latest special situations
- browse and analyze public companies, executives and SEC filings
Tickerverse is a great way to find investment opportunities in corporate actions.
By signing up you agree to our Terms of Service and Privacy Policy.